Sogroya
Somapacitan-beco · Novo Nordisk
PRESCRIPTION ONLY (USA)Sogroya ingredients
| Active ingredient | Strength |
|---|---|
| Somapacitan | 10 mg/mL, 6.7 mg/mL, 3.3 mg/mL |
What Sogroya is used for
Sogroya is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Sogroya
- Generic name
- Somapacitan-beco
- Made by
- Novo Nordisk
- Forms
- Injection, Solution
- Given
- Subcutaneous
- FDA approval
- Biologic licence (BLA) BLA761156
- On the US market since
- 2023
Official information
- Sogroya prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Somapacitan-beco)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Sogroya?
Sogroya (Somapacitan-beco) is a specialist medicine made by Novo Nordisk, approved by the US FDA.
What are the ingredients of Sogroya?
Sogroya contains Somapacitan (10 mg/mL, 6.7 mg/mL, 3.3 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA